Clinical trials
Phase 1 trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,949 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 10 |
| 2007 | 17 |
| 2008 | 29 |
| 2009 | 47 |
| 2010 | 51 |
| 2011 | 81 |
| 2012 | 99 |
| 2013 | 103 |
| 2014 | 114 |
| 2015 | 94 |
| 2016 | 92 |
| 2017 | 105 |
| 2018 | 107 |
| 2019 | 109 |
| 2020 | 139 |
| 2021 | 163 |
| 2022 | 144 |
| 2023 | 132 |
| 2024 | 119 |
| 2025 | 109 |
| 2026 | 80 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,345 |
| Unknown status | 201 |
| Recruiting | 145 |
| Terminated | 107 |
| Active, not recruiting | 96 |
| Not yet recruiting | 43 |
| Withdrawn | 9 |
| Enrolling by invitation | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chong Kun Dang Pharmaceutical | 181 |
| Hanmi Pharmaceutical Company Limited | 82 |
| Daewoong Pharmaceutical Co. LTD. | 73 |
| Seoul National University Hospital | 67 |
| Boryung Pharmaceutical Co., Ltd | 62 |
| Dong-A ST Co., Ltd. | 61 |
| HK inno.N Corporation | 55 |
| Yuhan Corporation | 46 |
| Novartis Pharmaceuticals | 42 |
| Addpharma Inc. | 41 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 125 |
| Carcinoma, Non-Small-Cell Lung | 104 |
| Hypertension | 98 |
| Diabetes Mellitus, Type 2 | 81 |
| Dyslipidemias | 51 |
| Colorectal Neoplasms | 50 |
| Neoplasm Metastasis | 47 |
| Stomach Neoplasms | 47 |
| Breast Neoplasms | 44 |
| Hyperlipidemias | 37 |
Trials
Showing 1 to 25 of 1,949. Each trial links to its page on Pharma Observatory.
1,849 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.